Crane Company (CR) — Fair Value Analysis
Base-case fair value (P50): $161.75 · Current price: $204.00 · Verdict: Overvalued
The Verdict on CR
CRANE (CR) appears Overvalued according to our Monte Carlo simulations, which project a median fair value (P50) of $161.75. This assessment suggests CR's current trading price of $204.00 carries a significant premium. Our analysis indicates a potential -20.7% downside, marking CR as a less attractive proposition at its present valuation. The Monte Carlo approach, simulating thousands of forward scenarios, consistently points to a substantial gap between the market price and the intrinsic value derived from fundamental drivers. This robust simulation provides a probabilistic framework for understanding CR's valuation discrepancies.
How CR stacks up against peers
CRANE's operational and financial health is categorized as average within its sector. While an average quality tier doesn't inherently imply overvaluation, when coupled with the observed disparity between the $204.00 and our median fair value of $161.75, it suggests that the market may be pricing in growth or stability that is not fully supported by its current fundamentals relative to peers. The -20.7% signal reinforces this view, indicating that CRANE is trading at a level that an average-tier company might struggle to justify over the long term, particularly given the inherent risks in any sector.
What this means for investors
For investors considering CRANE, the primary takeaway is the current Overvalued verdict. The substantial -20.7% gap between the $204.00 and the median fair value of $161.75 points to a high probability of negative returns from current levels. Given CRANE's average quality tier, this premium valuation warrants caution. While the Monte Carlo simulations consider various market conditions, the current data strongly suggests that CR is trading above its likely intrinsic value. To gain a deeper understanding of the full probability distribution, including detailed bear-case (P10) and bull-case (P90) scenarios for CRANE, sign up for a free FairCurve account and track CR's fair value as new fundamentals are released.
Frequently Asked Questions
Is CR overvalued or undervalued right now?
Based on our Monte Carlo simulations, CRANE (CR) is currently overvalued, with its current price of $204.00 trading significantly above our median fair value (P50) of $161.75.
What is the bear case and bull case for CR?
The full Monte Carlo distribution, including specific bear-case (P10) and bull-case (P90) target prices, along with the probability of upside from current levels, is available to users with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate CR's fair value?
FairCurve employs advanced Monte Carlo simulations to calculate CR's fair value, running thousands of forward scenarios to determine a probabilistic range for its intrinsic value. This approach accounts for various market dynamics and fundamental inputs.
How can I track CR's fair value as it changes?
You can add CRANE (CR) to a free FairCurve watchlist to receive daily fair-value updates. Our system instantly re-values CR when new earnings reports or significant fundamental data are released.